Abbott (ABT) Acquires Walk Vascular
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St futures flat after tech rout; Iran tensions, retail earnings in focus
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Global bond rout pauses as sovereign yields back off multi-decade highs
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
Abbott Labs' (ABT) Amulet Could Gain 30% Share - BofA Securities
August 31, 2021 8:46 AM EDTBofA Securities analyst Bob Hopkins reiterated a Buy rating and $133.00 price target on Abbott Labs (NYSE: ABT) after data from the European Society of Cardiology indicates that Amulet will be a major new product for the company. The analyst is modeling $230m in... More
Abbott Labs (ABT) PT Raised to $136 at BTIG
August 31, 2021 7:37 AM EDTBTIG analyst Marie Thibault raised the price target on Abbott Labs (NYSE: ABT) to $136.00 (from $126.00) while maintaining a Buy rating.... More
